UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Decision-Making Strategy for Rectal Cancer Management Using Radiation Therapy for Elderly or Comorbid Patients

International journal of radiation oncology, biology, physics, 2018-03, Vol.100 (4), p.926-944

2018

Volltextzugriff (PDF)

Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation

JAMA surgery, 2016-03, Vol.151 (3), p.234

2016

Volltextzugriff (PDF)

Abstract CT283: KEYNOTE-966: A randomized, double-blind, placebo-controlled, phase 3 study of pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract carcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT283-CT283

2020

Volltextzugriff (PDF)

Health-related quality of life (HRQoL) in the phase 3 KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) versus placebo plus gem/cis for advanced biliary tract cancer (BTC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4003-4003

2023

Volltextzugriff (PDF)

Unusual Case of Esophageal Adenocarcinoma With Forearm Soft Tissue Metastasis: 1663

The American journal of gastroenterology, 2017-10, Vol.112, p.S901

2017

Volltextzugriff (PDF)

Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis

Future oncology (London, England), 2024-04, Vol.20 (13), p.863-876

2024

Volltextzugriff (PDF)

Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates

Molecular cancer therapeutics, 2020-01, Vol.19 (1), p.304-311

2020

Volltextzugriff (PDF)

Impact of Smoking on Stage I-III Gastric Cancer: A Single-Center Retrospective Study: 183

The American journal of gastroenterology, 2014-10, Vol.109, p.S55-S56

2014

Volltextzugriff (PDF)

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

Cancer research (Chicago, Ill.), 2018-09, Vol.78 (18), p.5398-5407

2018

Volltextzugriff (PDF)

Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4587-4587

2020

Volltextzugriff (PDF)

Predictors of need for urgent enteral feeding access in esophageal cancer patients during neoadjuvant or definitive chemoradiation

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15054-e15054

2015

Volltextzugriff (PDF)

Management of locally advanced rectal cancer in the elderly: a critical review and algorithm

Journal of gastrointestinal oncology, 2018-04, Vol.9 (2), p.363-376

2018

Volltextzugriff (PDF)

Safety and pharmacodynamics of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2595-2595

2018

Volltextzugriff (PDF)

Evaluation of a 4‐protein serum biomarker panel—biglycan, annexin‐A6, myeloperoxidase, and protein S100‐A9 (B‐AMP)—for the detection of esophageal adenocarcinoma

Cancer, 2014-12, Vol.120 (24), p.3902-3913

2014

Volltextzugriff (PDF)

Prognostic implications of signet ring cell histology in esophageal adenocarcinoma

Cancer, 2013-09, Vol.119 (17), p.3156-3161

2013

Volltextzugriff (PDF)

Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial

Oncology, 2013-01, Vol.85 (1), p.53-58

2013

Volltextzugriff (PDF)

Gemcitabine (G), capecitabine (C) and bevacizumab (BV) in patients with advanced biliary cancers (ABC): final results of a multicenter phase II study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4078-4078

2015

Volltextzugriff (PDF)

Mo1641 Complete Pathologic Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1159-S-1159

2015

Volltextzugriff (PDF)

A phase IB study of the combination of selumetinib (AZD6244, ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2587-2587

2017

Volltextzugriff (PDF)

Prevention of Barrett Esophagus and Esophageal Adenocarcinoma by Smoothened Inhibitor in a Rat Model of Gastroesophageal Reflux Disease

Annals of surgery, 2013-07, Vol.258 (1), p.82-88

2013

Volltextzugriff (PDF)

A phase II trial of pralatrexate (P) plus oxaliplatin (O) in advanced esophago-gastric cancer (aEGC): survival analysis and pharmacogenetic correlates

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15037-e15037

2015

Volltextzugriff (PDF)

A phase IB study of the combination of selumetinib (AZD6244; ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.609-609

2017

Volltextzugriff (PDF)

ALBI score and outcomes in patients with hepatocellular carcinoma: analysis of the randomized controlled trial KEYNOTE-240

Therapeutic advances in medical oncology, 2021-09, Vol.13

2021

Volltextzugriff (PDF)

Prognostic implications of signet ring cell histology in esophageal adenocarcinoma: A SEER database analysis

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4067-4067

2013

Volltextzugriff (PDF)

Smoothened Inhibition Leads to Decreased Proliferation and Induces Apoptosis in Esophageal Adenocarcinoma Cells

Cancer investigation, 2013-08, Vol.31 (7), p.480-489

2013

Volltextzugriff (PDF)

26 – 50 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(187)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Decision-Making Strategy for Rectal Cancer Management Using Radiation Therapy for Elderly or Comorbid Patients

Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation

Abstract CT283: KEYNOTE-966: A randomized, double-blind, placebo-controlled, phase 3 study of pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract carcinoma

Health-related quality of life (HRQoL) in the phase 3 KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) versus placebo plus gem/cis for advanced biliary tract cancer (BTC)

Unusual Case of Esophageal Adenocarcinoma With Forearm Soft Tissue Metastasis: 1663

Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis

Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates

Impact of Smoking on Stage I-III Gastric Cancer: A Single-Center Retrospective Study: 183

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240

Predictors of need for urgent enteral feeding access in esophageal cancer patients during neoadjuvant or definitive chemoradiation

Management of locally advanced rectal cancer in the elderly: a critical review and algorithm

Safety and pharmacodynamics of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

Evaluation of a 4‐protein serum biomarker panel—biglycan, annexin‐A6, myeloperoxidase, and protein S100‐A9 (B‐AMP)—for the detection of esophageal adenocarcinoma

Prognostic implications of signet ring cell histology in esophageal adenocarcinoma

Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial

Gemcitabine (G), capecitabine (C) and bevacizumab (BV) in patients with advanced biliary cancers (ABC): final results of a multicenter phase II study

Mo1641 Complete Pathologic Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma

A phase IB study of the combination of selumetinib (AZD6244, ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)

Prevention of Barrett Esophagus and Esophageal Adenocarcinoma by Smoothened Inhibitor in a Rat Model of Gastroesophageal Reflux Disease

A phase II trial of pralatrexate (P) plus oxaliplatin (O) in advanced esophago-gastric cancer (aEGC): survival analysis and pharmacogenetic correlates

A phase IB study of the combination of selumetinib (AZD6244; ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)

ALBI score and outcomes in patients with hepatocellular carcinoma: analysis of the randomized controlled trial KEYNOTE-240

Prognostic implications of signet ring cell histology in esophageal adenocarcinoma: A SEER database analysis

Smoothened Inhibition Leads to Decreased Proliferation and Induces Apoptosis in Esophageal Adenocarcinoma Cells

Suchergebnisse filtern